药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Bismuth subsalicylate
Certolizumab pegol
The metabolism of Regorafenib can be increased when combined with Certolizumab pegol.
Bismuth subsalicylate
Golimumab
The metabolism of Regorafenib can be increased when combined with Golimumab.
Bismuth subsalicylate
Rilonacept
The metabolism of Regorafenib can be increased when combined with Rilonacept.
Bismuth subsalicylate
Canakinumab
The metabolism of Regorafenib can be increased when combined with Canakinumab.
Bismuth subsalicylate
Afelimomab
The metabolism of Regorafenib can be increased when combined with Afelimomab.
Bismuth subsalicylate
Siltuximab
The metabolism of Regorafenib can be increased when combined with Siltuximab.
Bismuth subsalicylate
Tocilizumab
The metabolism of Regorafenib can be increased when combined with Tocilizumab.
Bismuth subsalicylate
Methylene blue
The metabolism of Methylene blue can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Umifenovir
The metabolism of Umifenovir can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Deferasirox
The metabolism of Regorafenib can be decreased when combined with Deferasirox.
Bismuth subsalicylate
Artesunate
The metabolism of Artesunate can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Vadimezan
The metabolism of Vadimezan can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Ertugliflozin
The metabolism of Ertugliflozin can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Artenimol
The metabolism of Artenimol can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Ketobemidone
The metabolism of Ketobemidone can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Tapentadol
The metabolism of Tapentadol can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Cholestyramine
Cholestyramine can cause a decrease in the absorption of Regorafenib resulting in a reduced serum concentration and potentially a decrease in efficacy.
Bismuth subsalicylate
Cabozantinib
The metabolism of Cabozantinib can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Fluindione
The metabolism of Fluindione can be decreased when combined with Regorafenib.
Bismuth subsalicylate
Candesartan
The metabolism of Candesartan can be decreased when combined with Regorafenib.